ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,017, issued on Nov. 3, was assigned to CHENGDU AODA BIOTECHNOLOGY Co. LTD (Chengdu, China).
"Exenatide analog" was invented by Shuliang Zhou (Chengdu, China), Peng Wang (Chengdu, China) and Lan Deng (Chengdu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of pharmaceutical synthesis, and disclosed is an exenatide analog. The exenatide analog is used for preparing a pharmaceutical composition for treating diseases. Also disclosed is a use of the pharmaceutical composition in preparation of medicines for treating at least one of the following diseases: type-II diabetes, impaired glucose tolerance, type-I...